TRIAMTERENE AND HYDROCHLOROTHIAZIDE
... risked. 1. Triamterene and hydrochlorothiazide tablets are indicated for the treatment of hypertension or edema in patients who develop hypokalemia on hydrochlorothiazide alone. 2. Triamterene and hydrochlorothiazide is also indicated for those patients who require a thiazide diuretic and in whom th ...
... risked. 1. Triamterene and hydrochlorothiazide tablets are indicated for the treatment of hypertension or edema in patients who develop hypokalemia on hydrochlorothiazide alone. 2. Triamterene and hydrochlorothiazide is also indicated for those patients who require a thiazide diuretic and in whom th ...
Clorhidrato de Propranolol. Monografia del farmaco.
... randomized, double-blind, placebo-controlled trial conducted in 31 US centers (plus one in Canada) in 3837 persons without history of severe congestive heart failure or presence of recent heart failure; certain conduction defects; angina since infarction, who had survived the acute phase of myocardi ...
... randomized, double-blind, placebo-controlled trial conducted in 31 US centers (plus one in Canada) in 3837 persons without history of severe congestive heart failure or presence of recent heart failure; certain conduction defects; angina since infarction, who had survived the acute phase of myocardi ...
Clinical overview - WHO archives
... artesunate.7 In addition, the use of combination therapy has an impact on malaria transmission by lowering rates of gametocytaemia after treatment.17 There are different ways to combine antimalarial drugs. Compliance with sequential combination regimen is notoriously poor; patients are reluctant to ...
... artesunate.7 In addition, the use of combination therapy has an impact on malaria transmission by lowering rates of gametocytaemia after treatment.17 There are different ways to combine antimalarial drugs. Compliance with sequential combination regimen is notoriously poor; patients are reluctant to ...
AusPAR Nivolumab - Therapeutic Goods Administration
... NCCN did recommend nivolumab (among other options) as first line therapy in all settings, but did not endorse nivolumab + ipilimumab combination therapy. It may be argued disease control by BRAF inhibitors is transient. With combined BRAF and MEK inhibition, progression has been delayed for many: me ...
... NCCN did recommend nivolumab (among other options) as first line therapy in all settings, but did not endorse nivolumab + ipilimumab combination therapy. It may be argued disease control by BRAF inhibitors is transient. With combined BRAF and MEK inhibition, progression has been delayed for many: me ...
ibogaine: a review
... which it naturally occurs, and its chemical structure cannot be patented. This has left the academic community and the public sector with a crucial role in research on ibogaine, which was a major reason for organizing the First International Conference on Ibogaine. A major focus of the Conference wa ...
... which it naturally occurs, and its chemical structure cannot be patented. This has left the academic community and the public sector with a crucial role in research on ibogaine, which was a major reason for organizing the First International Conference on Ibogaine. A major focus of the Conference wa ...
MICROMEDEX® Healthcare Series OXCARBAZEPINE
... 1.4.1.A.1 Partial seizure, monotherapy a) Conversion 1) For conversion of therapy from other antiepileptic drugs (AEDs) to oxcarbazepine monotherapy in children 4 to 16 years, oxcarbazepine therapy should be initiated with a dose of 8 to 10 milligrams/kilogram/day (mg/kg/day in two divided doses; si ...
... 1.4.1.A.1 Partial seizure, monotherapy a) Conversion 1) For conversion of therapy from other antiepileptic drugs (AEDs) to oxcarbazepine monotherapy in children 4 to 16 years, oxcarbazepine therapy should be initiated with a dose of 8 to 10 milligrams/kilogram/day (mg/kg/day in two divided doses; si ...
ZITHROMAX (azithromycin tablets) and
... In asymptomatic HIV-seropositive adult subjects receiving 600-mg ZITHROMAX tablets once daily for 22 days, steady state azithromycin serum levels were achieved by Day 15 of dosing. When azithromycin capsules were administered with food, the rate of absorption (Cmax) of azithromycin was reduced by 52 ...
... In asymptomatic HIV-seropositive adult subjects receiving 600-mg ZITHROMAX tablets once daily for 22 days, steady state azithromycin serum levels were achieved by Day 15 of dosing. When azithromycin capsules were administered with food, the rate of absorption (Cmax) of azithromycin was reduced by 52 ...
St John`s wort (Hypericum perforatum L.): a review of its
... al 1999 ; Panocka et al 2000). One of these studies, which involved a dry extract of hypericum containing 0.3 % hypericin and 3.8 % hyperforin, reported that the antidepressant activity may be mediated by interaction with sigma receptors and by increased serotonergic transmission (Panocka et al 2000 ...
... al 1999 ; Panocka et al 2000). One of these studies, which involved a dry extract of hypericum containing 0.3 % hypericin and 3.8 % hyperforin, reported that the antidepressant activity may be mediated by interaction with sigma receptors and by increased serotonergic transmission (Panocka et al 2000 ...
Low-Dose Methotrexate: A Mainstay in the Treatment of Rheumatoid
... Thus, for a drug such as methotrexate in which different doses of the drug have very different clinical uses, high doses to prevent proliferation of malignant cells and very low doses over prolonged periods to treat inflammatory diseases, the concentration of the drug used in a given in vitro experi ...
... Thus, for a drug such as methotrexate in which different doses of the drug have very different clinical uses, high doses to prevent proliferation of malignant cells and very low doses over prolonged periods to treat inflammatory diseases, the concentration of the drug used in a given in vitro experi ...
Full Product Information
... As salbutamol is probably secreted in breast milk its use in nursing mothers is not recommended unless the expected benefits outweigh any potential risk. It is not known whether salbutamol in breast milk has a harmful effect on the neonate. ...
... As salbutamol is probably secreted in breast milk its use in nursing mothers is not recommended unless the expected benefits outweigh any potential risk. It is not known whether salbutamol in breast milk has a harmful effect on the neonate. ...
Literary review compilation on massage
... 57. Psychological treatments to help people with cystic fibrosis and their carers manage the disease ... 54 59. Non-drug therapies for lower limb muscle cramps ........................................................................... 55 66. Spiritual and religious interventions for adults in the l ...
... 57. Psychological treatments to help people with cystic fibrosis and their carers manage the disease ... 54 59. Non-drug therapies for lower limb muscle cramps ........................................................................... 55 66. Spiritual and religious interventions for adults in the l ...
Naproxen Naproxen Sodium
... Results from a large, prospective, population-based cohort study in geriatric individuals indicate a lower prevalence of Alzheimer’s disease† among patients who received an NSAIA for 2 years or longer. Similar findings have been reported from some other, but not all, observational studies. ...
... Results from a large, prospective, population-based cohort study in geriatric individuals indicate a lower prevalence of Alzheimer’s disease† among patients who received an NSAIA for 2 years or longer. Similar findings have been reported from some other, but not all, observational studies. ...
Guidelines for the Use of Antiretroviral Agents in
... formulations for treatment-naive individuals. On the basis of data from long-term follow-up studies and experience in clinical practice, the Panel recognizes that options for initial therapy have expanded. Consequently, the Panel now refers to options for initial treatment as “Recommended” rather t ...
... formulations for treatment-naive individuals. On the basis of data from long-term follow-up studies and experience in clinical practice, the Panel recognizes that options for initial therapy have expanded. Consequently, the Panel now refers to options for initial treatment as “Recommended” rather t ...
Medical Emergencies and Adverse Events in Ecstasy Users
... above estimate. The researchers found that 8 of 329 users had presented to an ED with an ecstasy-related problem in the previous 6 months. Given the data in this report, it can be calculated (see Table 6.1) that there were at most 7305 episodes of ecstasy use by these users in this period. Because t ...
... above estimate. The researchers found that 8 of 329 users had presented to an ED with an ecstasy-related problem in the previous 6 months. Given the data in this report, it can be calculated (see Table 6.1) that there were at most 7305 episodes of ecstasy use by these users in this period. Because t ...
Lipid Formulations of Amphotericin B: Recent Progress and Future
... In attempting to explain why the product developed by Berestein and Juliano could be significantly less toxic than conventional amphotericin B while maintaining its efficacy, Janoff and colleagues began a series of experiments to study this form of lipid-associated amphotericin B in their laboratory ...
... In attempting to explain why the product developed by Berestein and Juliano could be significantly less toxic than conventional amphotericin B while maintaining its efficacy, Janoff and colleagues began a series of experiments to study this form of lipid-associated amphotericin B in their laboratory ...
P M harmacist’s anual
... Mark W. Caverly Chief, Liaison and Policy Section This manual has been prepared by the Drug Enforcement Administration, Office of Diversion Control, as a guide to assist pharmacists in their understanding of the Federal Controlled Substances Act and its implementing regulations as they pertain to th ...
... Mark W. Caverly Chief, Liaison and Policy Section This manual has been prepared by the Drug Enforcement Administration, Office of Diversion Control, as a guide to assist pharmacists in their understanding of the Federal Controlled Substances Act and its implementing regulations as they pertain to th ...
psychoactive substances
... to take account of medical practice. These schedules allow exceptions to the general prohibitions on the possession supply and use of controlled drugs. Schedule 1. Schedule 1 lists mainly hallucinogenic drugs that have no medical use at present. It also includes some of the ’designer’ drugs’. The dr ...
... to take account of medical practice. These schedules allow exceptions to the general prohibitions on the possession supply and use of controlled drugs. Schedule 1. Schedule 1 lists mainly hallucinogenic drugs that have no medical use at present. It also includes some of the ’designer’ drugs’. The dr ...
Radioactive Microspheres - Scientific and Clinical Applications of
... Short-lived radioisotopes (Table 3) can be used to optimize radiobiologic aspects of therapy. Specifically, it has been shown that not only the total dose, but the dose-rate is very important for the treatment outcome in radiotherapy (28). Short-lived radioisotopes such as 165Dy or 188Re pack the "p ...
... Short-lived radioisotopes (Table 3) can be used to optimize radiobiologic aspects of therapy. Specifically, it has been shown that not only the total dose, but the dose-rate is very important for the treatment outcome in radiotherapy (28). Short-lived radioisotopes such as 165Dy or 188Re pack the "p ...
mesna injection, 100 mg/ml
... Clinical studies of mesna did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, reflecting the greater frequency of decreased hepatic, renal, or cardia ...
... Clinical studies of mesna did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, reflecting the greater frequency of decreased hepatic, renal, or cardia ...
idarubicin
... idarubicin total cumulative doses up to 400 mg/m2 suggest a low probability of cardiotoxicity. Cardiac function should be assessed before patients undergo treatment with idarubicin and must be monitored throughout therapy to minimize the risk of incurring severe cardiac impairment. The risk may be d ...
... idarubicin total cumulative doses up to 400 mg/m2 suggest a low probability of cardiotoxicity. Cardiac function should be assessed before patients undergo treatment with idarubicin and must be monitored throughout therapy to minimize the risk of incurring severe cardiac impairment. The risk may be d ...
Investigator`s Brochure - Multidisciplinary Association for
... illness. MDMA was administered to thousands of people prior to scheduling and millions continue to use ecstasy around the world in various non-medical settings [14-18]. While a number of serious adverse events, including fatalities, have been reported after non-medical ecstasy and poly-drug use in u ...
... illness. MDMA was administered to thousands of people prior to scheduling and millions continue to use ecstasy around the world in various non-medical settings [14-18]. While a number of serious adverse events, including fatalities, have been reported after non-medical ecstasy and poly-drug use in u ...
Polyethylene Glycol: A Game-Changer Laxative for Children
... duration ranging from 2 weeks to 6 months (18–23). Five studies assessed the efficacy in children with functional constipation, whereas 1 study involved children with neurogenic constipation resulting from meningomyelocele (23). PEG was used in 4 studies, whereas PEG þ E was used in 2 other studies. ...
... duration ranging from 2 weeks to 6 months (18–23). Five studies assessed the efficacy in children with functional constipation, whereas 1 study involved children with neurogenic constipation resulting from meningomyelocele (23). PEG was used in 4 studies, whereas PEG þ E was used in 2 other studies. ...
QUINIDINE GLUCONATE INJECTION, USP
... Presumably because both drugs are metabolized by cyctochrome P450IIIA4, coadministration of quinidine causes variable slowing of the metabolism of nifedipine. Interactions with other dihydropyridine calcium-channel blockers have not been reported, but these agents (including felodipine, nicardipine, ...
... Presumably because both drugs are metabolized by cyctochrome P450IIIA4, coadministration of quinidine causes variable slowing of the metabolism of nifedipine. Interactions with other dihydropyridine calcium-channel blockers have not been reported, but these agents (including felodipine, nicardipine, ...
Consensus Guidelines for the Management of
... of surgery as a risk factor is still debated. New evidence suggests that cholecystectomy: 1.90 (1.36–2.68), gynecological surgery: 1.24 (1.02–1.52), and laparoscopic: 1.37 (1.07–1.77) approach are associated with a higher incidence of PONV when compared with general surgery as a reference group.20 T ...
... of surgery as a risk factor is still debated. New evidence suggests that cholecystectomy: 1.90 (1.36–2.68), gynecological surgery: 1.24 (1.02–1.52), and laparoscopic: 1.37 (1.07–1.77) approach are associated with a higher incidence of PONV when compared with general surgery as a reference group.20 T ...
Consensus guidelines for the management of postoperative nausea
... of surgery as a risk factor is still debated. New evidence suggests that cholecystectomy: 1.90 (1.36–2.68), gynecological surgery: 1.24 (1.02–1.52), and laparoscopic: 1.37 (1.07–1.77) approach are associated with a higher incidence of PONV when compared with general surgery as a reference group.20 T ...
... of surgery as a risk factor is still debated. New evidence suggests that cholecystectomy: 1.90 (1.36–2.68), gynecological surgery: 1.24 (1.02–1.52), and laparoscopic: 1.37 (1.07–1.77) approach are associated with a higher incidence of PONV when compared with general surgery as a reference group.20 T ...